文献速递胸部CT

定量胸部CT分析鉴别COVID-19与非COVID-19患者

Quantitative Chest CT analysis in discriminating COVID-19 from non-COVID-19 patients.
PubMed 文献 · Radiol Med · 2020-10-12

回顾性纳入2020年3月31日至4月18日胸部CT提示间质性肺炎的190例患者,按RT-PCR结果分为COVID-19组136例和非COVID-19组54例,用专用软件定量分析肺容积、健康肺实质、磨玻璃影、实变和纤维化改变。COVID-19组磨玻璃影和纤维化改变容积均高于非COVID-19组,ROC曲线下面积分别为0.661和0.698。

要点

  • 定量CT显示COVID-19组磨玻璃影容积高于非COVID-19组(0.55±0.26L vs 0.43±0.23L,p=0.0005)。
  • 纤维化改变容积COVID-19组亦高于非COVID-19组(0.05±0.03L vs 0.04±0.03L,p<0.0001)。
  • 纤维化改变 cutoff 0.02L 时敏感度86%、特异度44%,鉴别能力有限。

关键影像表现/征象

  • COVID-19组磨玻璃影容积0.55±0.26L,非COVID-19组0.43±0.23L,p=0.0005。
  • COVID-19组纤维化改变容积0.05±0.03L,非COVID-19组0.04±0.03L,p<0.0001。

诊断标准与关键数值

  • 磨玻璃影鉴别COVID-19的ROC曲线下面积0.661,cutoff 0.39L,敏感度68%,特异度59%,p<0.001。
  • 纤维化改变鉴别COVID-19的ROC曲线下面积0.698,cutoff 0.02L,敏感度86%,特异度44%,p<0.001。

临床应用与阅片要点

  • 定量CT提供的磨玻璃影和纤维化改变容积可作为鉴别COVID-19与非COVID-19的辅助信息。
  • 软件分割不充分时需由放射科医师手动调整受累区域后再行定量分析。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: COVID-19 pneumonia is characterized by ground-glass opacities (GGOs) and consolidations on Chest CT, although these CT features cannot be considered specific, at least on a qualitative analysis. The aim is to evaluate if Quantitative Chest CT could provide reliable information in discriminating COVID-19 from non-COVID-19 patients.

MATERIALS AND METHODS: From March 31, 2020 until April 18, 2020, patients with Chest CT suggestive for interstitial pneumonia were retrospectively enrolled and divided into two groups based on positive/negative COVID-19 RT-PCR results. Patients with pulmonary resection and/or CT motion artifacts were excluded. Quantitative Chest CT analysis was performed with a dedicated software that provides total lung volume, healthy parenchyma, GGOs, consolidations and fibrotic alterations, expressed both in liters and percentage. Two radiologists in consensus revised software analysis and adjusted areas of lung impairment in case of non-adequate segmentation. Data obtained were compared between COVID-19 and non-COVID-19 patients and p < 0.05 were considered statistically significant. Performance of statistically significant parameters was tested by ROC curve analysis.

RESULTS: Final population enrolled included 190 patients: 136 COVID-19 patients (87 male, 49 female, mean age 66 ± 16) and 54 non-COVID-19 patients (25 male, 29 female, mean age 63 ± 15). Lung quantification in liters showed significant differences between COVID-19 and non-COVID-19 patients for GGOs (0.55 ± 0.26L vs 0.43 ± 0.23L, p = 0.0005) and fibrotic alterations (0.05 ± 0.03 L vs 0.04 ± 0.03 L, p < 0.0001). ROC analysis of GGOs and fibrotic alterations showed an area under the curve of 0.661 (cutoff 0.39 L, 68% sensitivity and 59% specificity, p < 0.001) and 0.698 (cutoff 0.02 L, 86% sensitivity and 44% specificity, p < 0.001), respectively.

CONCLUSIONS: Quantification of GGOs and fibrotic alterations on Chest CT could be able to identify patients with COVID-19.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Caruso D, Polici M, Zerunian M, et al. Quantitative Chest CT analysis in discriminating COVID-19 from non-COVID-19 patients. Radiol Med. 2020. PMID: 33044733. doi:10.1007/s11547-020-01291-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。